跳至主要内容
临床试验/ISRCTN89619994
ISRCTN89619994
已完成
未知

Time course of biochemical markers of inflammation, oxidative stress and wound healing after ablation of atrial fibrillation

Medical University of Vienna (Austria)0 个研究点目标入组 30 人2007年12月11日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
Medical University of Vienna (Austria)
入组人数
30
状态
已完成
最后更新
6年前

概览

简要总结

  1. 2011 results in: https://www.ncbi.nlm.nih.gov/pubmed/20692054 (added 31/05/2019) 2. 2012 results in: https://www.ncbi.nlm.nih.gov/pubmed/22102100 (added 31/05/2019)
注册库
who.int
开始日期
2007年12月11日
结束日期
2008年8月1日
最后更新
6年前
研究类型
Observational
性别
All

研究者

发起方
Medical University of Vienna (Austria)

入排标准

入选标准

  • 1\. Genders eligible for study: both
  • 2\. Age older than 18 years
  • 3\. Symptomatic, drug\-resistant paroxysmal atrial fibrillation (self\-terminating episodes lasting less than 7 days)
  • 4\. Patients referred to our department for catheter ablation of atrial fibrillation
  • 5\. Adequate anticoagulation for at least 1 month prior to admission (oral anticoagulation (target International Normalised Ratio \[INR] 2 to 3\) or treatment with weight\-adjusted low\-molecular\-weight heparin

排除标准

  • 1\. Pregnancy
  • 2\. Ongoing infections
  • 3\. Intracardiac thrombosis detected by trans\-oesophageal echocardiography
  • 4\. Contraindications to anticoagulation
  • 5\. History of myocardial infarction or cardiac surgery within the last 3 months prior to admission
  • 6\. Pacemaker or other contraindications to Magnetic Resonance Imaging (MRI)
  • 7\. Denial or withdrawal of informed consent
  • 8\. Life expectancy less than 1 year

结局指标

主要结局

未指定

相似试验